Depression can be associated with behaviours such as social avoidance, that is, the refusal to interact with others for fear of being judged or criticized. Physicians and other mental health workers have noted that patients with depressive disorders exhibit cognitive symptoms, especially with regard to memory.
Published on: 13 Aug 2019
Marc Miller, Member of Parliament (Ville-Marie–Le Sud-Ouest–Île-des-Sœurs, Quebec) and Parliamentary Secretary to the Minister of Crown-Indigenous Relations, on behalf of the Honourable Ginette Petitpas Taylor, Minister of Health, announced today at McGill an investment of up to $6 million for a scientific task force of top researchers to develop new and improved approaches to cancer treatment and care. The funding will be distributed over four years to the new pan-Canadian program, the Stand Up to Cancer (SU2C) Canada Metastatic Breast Cancer Dream Team.
Published on: 12 Aug 2019
The Canadian Applied and Industrial Mathematical Society presented the Research Prize to Dr. Leon Glass for his contributions to research, education and community leadership. Click here for details.
Published on: 22 Jul 2019
The recipient of the 2019 Louis and Artur Lucian Award is Dr. Joseph Hill from the University of Texas Southwestern Medical Center. The award, established through a bequest to McGill University by the late Olga Leibovici to honour her two brothers, was designed to honour outstanding research in the field of circulatory diseases by a scientific investigator or group of investigators whose contribution to knowledge in this field is deemed worthy of special recognition.
Category:
Published on: 12 Jul 2019
MONCTON, NB – The federal Minister of Health, Ginette Petitpas Taylor, announced today an investment of $150 million over five years by the Government of Canada for the creation of the Marathon of Hope Cancer Centres network.
The network, which includes McGill University and is led by the Terry Fox Research Institute (TFRI), will unite cancer centres across Canada for the first time, accelerating the implementation of precision medicine so that Canadian cancer patients can access the right treatment at the right time for their particular cancer, no matter where they live.
Category:
Published on: 11 Jul 2019
We are pleased to announce the appointment of Dr Julian Huertas Garcia to the Department of Medicine as of 1 July 2019.
Dr Huertas-Garcia has been appointed to the Attending Staff of the MUHC Department of Medicine, Division of General Internal Medicine, based at the Lachine Hospital, and as an Assistant Professor in the McGill University Department of Medicine.
Category:
Published on: 11 Jul 2019
Source: Terry Fox Research Institute
What is the best way to starve cancer cells? What role does obesity play in metastatic breast cancer and how does it affect the tumour microenvironment? Might combining a chemotherapeutic agent with a drug now used to treat diabetes be part of an effective therapy for metastatic breast cancer?
Published on: 4 Jul 2019
New research led by McGill’s Goodman Cancer Research Centre improves our understanding of microRNAs
Published on: 27 Jun 2019
Discovery could provide clues to potential therapies
Rearing its head in infancy, Christianson Syndrome is a rare disorder whose symptoms include intellectual disability, seizures and difficulty standing or walking. Although it is becoming increasingly diagnosed, with little being known about the neural mechanism behind the disease, therapeutic options for patients remain limited.
Published on: 27 Jun 2019
Heart & Stroke and McGill University to create Early-Career Professorship in Women’s Heart Health
Montréal, June 18, 2019 – The first research chair in Quebec focused on women’s cardiac health, propelled by Heart & Stroke and McGill University, will officially be launched on July 1 via a research project led by Dr. Natalie Dayan, Assistant Professor of Medicine at McGill University’s Faculty of Medicine and Director of Obstetrical Medicine in the division of General Internal Medicine at the McGill University Health Centre (MUHC).
Category:
Published on: 18 Jun 2019
The Québec Cancer Consortium for Novel Therapeutics and Biomarkers (QCC), a collaboration between six leading hospital and cancer research centre sites based in Montreal led by McGill University’s Goodman Cancer Research Centre (GCRC) was awarded $10M in new funding from the Ministère de l’Économie et de l’Innovation (MEI) du Québec through its Fonds d’accélération des collaborations en santé (FACS) program.
Published on: 4 Jun 2019
Researchers find clue to rare genetic disorder
Leber hereditary optic neuropathy (LHON) is an inherited form of vision loss that causes people to have trouble with their colour vision and difficulty seeing in the centre of their visual field. Due to the founder effect from the filles du roi, there is a disproportionate preponderance of a particular LHON mutation among the French-Canadian population.
Published on: 22 May 2019
Background: The Macdonald-Stewart Library Building that houses the Schulich Library of Physical Sciences, Life Sciences, and Engineering will undergo significant structural repairs and major internal upgrades over the next two years, beginning May 15, 2019. As a result, Schulich Library is now closed temporarily. Collections, services and staff will be relocated to the Humanities and Social Sciences Library for the duration of the renovation.
Category:
Published on: 15 May 2019
Elwyn was a healthy 13 month-old toddler when she started drinking water from the bathtub. Over time, she became increasingly thirsty and demanded more and more breast milk. For her parents, this seemed like typical behaviour related to a growth spurt. One day, however, they noticed that she was abnormally weak and rushed her to the emergency department. She was diagnosed with type 1 diabetes and had already developed a life-threatening complication of the disease known as diabetic ketoacidosis.
Category:
Published on: 14 May 2019
Study could lead to development of personalized biomarkers and treatment
Individuals with autism spectrum disorder (ASD) are often lumped into a single catch-all group, despite significant differences in symptom profile and severity. Further muddying the waters when trying to understand and treat ASD, many previous studies show significant variability in findings.
Published on: 8 May 2019
Pages
